COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11.
The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11.
Health care providers should not purchase or use certain imported medical gloves from certain companies, which appear to have been reprocessed, cleaned or recycled and sold as new, the Food and Drug Administration announced.
Moderna announced an updated timeline for its COVID-19 vaccine for children. According to Moderna, the Food and Drug Administration last week notified the drug maker that it may not complete its assessment of the company’s EUA request for children age 12 to 17 before January 2022.
The recent expansion of COVID-19 booster shots for certain adult Americans means that millions more people are now eligible to seek extra protection against the deadly virus.
The Food and Drug Administration authorized Pfizer’s COVID-19 vaccine for pediatric use, moving the issue of administration to the Centers for Disease Control and Prevention for consideration.
In a study of over 7,000 adults hospitalized with COVID-19 symptoms, unvaccinated patients with prior SARS-CoV-2 infection were five times more likely to have laboratory-confirmed COVID-19 than were patients fully vaccinated against COVID-19 and no previous infection, the Centers for Disease…
As a Centers for Disease Control and Prevention advisory committee prepares to consider expanding COVID-19 vaccine eligibility to children aged 5-11, the AHA, American Academy of Pediatrics and Children’s Hospital Association will webcast a panel discussion Nov. 8 at 2 p.m. ET on how pediatricians…
A Food and Drug Administration advisory committee voted to recommend an emergency use authorization of Pfizer’s COVID-19 vaccine for children age 5-11.
In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and…